AVEO Pharmaceuticals, Inc(NASDAQ:AVEO) 
AVEO Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing and commercializing medicines for cancer patients. It markets its lead candidate, FOTIVDA, an oral, once-daily, vascular endothelial growth factor receptor tyrosine kinase inhibitor, which is used for the treatment of ren...
Website: http://www.aveooncology.com
Founded: 2001
Full Time Employees: 49 (May 2021)
Sector: Healthcare
Industry: Biotechnology
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2022-07-22
P
O 6.91
H 6.97
L 6.72
C 6.78
V 91,927
10EMA 6.78
20EMA 6.78
60EMA 6.78
120EMA 6.78
250EMA 6.78